首页> 外文OA文献 >PCN90 COMPARATIVE RETROSPECTIVE NON-RANDOMIZED PHARMACOECONOMIC TRIAL OF EFFICIENCY AND SAFETY OF USE OF PACLITAXELS (PACLITAXEL-LENS OR TAXOL) IN A MONOMODE FOR 2ND LINE OF TREATMENT OF METASTATIC BREAST CANCER PATIENTS

【2h】

PCN90 COMPARATIVE RETROSPECTIVE NON-RANDOMIZED PHARMACOECONOMIC TRIAL OF EFFICIENCY AND SAFETY OF USE OF PACLITAXELS (PACLITAXEL-LENS OR TAXOL) IN A MONOMODE FOR 2ND LINE OF TREATMENT OF METASTATIC BREAST CANCER PATIENTS

机译：PCN90在单反模式下第二线治疗转移性乳腺癌患者的有效性和安全性中使用帕可他赛尔（PACLITAXEL-LENS或TAXOL）的对比回顾性非随机药物经济学试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Pavlysh A; Kolbin A; Livshits R; Koroleva O; Manikhas A; Tkachenko E; Atrashevskaya N; Demicheva N;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: Efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group [J] . LückH.-J., DuBoisA., LoiblS., Breast cancer research and treatment. . 2013,第3期

机译：卡培他滨联合紫杉醇与表柔比星联合紫杉醇作为转移性乳腺癌的一线治疗：AGO乳腺癌研究小组进行的一项随机III期试验的疗效和安全性结果
2. A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer. [J] . Bryan M, Pulte ED, Toomey KC, Investigational new drugs. . 2011,第6期

机译：在患有复发性或转移性乳腺癌的患者中进行全反式维甲酸（Vesanoid）和紫杉醇（Taxol）的II期试验性试验。
3. Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety [J] . E Baldini, T Prochilo, B Salvadori, British Journal of Cancer . 2004,第1期

机译：表柔比星联合紫杉醇与表柔比星联合紫杉醇在转移性乳腺癌患者中的多中心随机III期试验：关注心脏安全
4. IG-001—A non-biologic micellar paclitaxel formulation for the treatment of metastatic Breast cancer [C] . Motamed Kouros, Hwang Larn, Hsiao Chao, IEEE International Conference on Nano/Molecular Medicine and Engineering . 2013

机译：IG-001—用于治疗转移性乳腺癌的非生物胶束紫杉醇制剂
5. Cost-Benefit Analysis of Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel for the Treatment of Metastatic Breast Cancer in the United States [D] . Vichansavakul, Kittaya 2013

机译：纳米白蛋白结合紫杉醇与溶剂型紫杉醇在美国治疗转移性乳腺癌的成本效益分析
6. Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety [O] . E Baldini, T Prochilo, B Salvadori, 2004

机译：表柔比星联合紫杉醇与表柔比星联合紫杉醇在转移性乳腺癌患者中的多中心随机III期试验：关注心脏安全
7. Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety [O] . Baldini, E, Prochilo, T, Salvadori, B, 2004

机译：表柔比星联合紫杉醇与表柔比星联合紫杉醇在转移性乳腺癌患者中的多中心随机III期试验：关注心脏安全

PCN90 COMPARATIVE RETROSPECTIVE NON-RANDOMIZED PHARMACOECONOMIC TRIAL OF EFFICIENCY AND SAFETY OF USE OF PACLITAXELS (PACLITAXEL-LENS OR TAXOL) IN A MONOMODE FOR 2ND LINE OF TREATMENT OF METASTATIC BREAST CANCER PATIENTS

著录项

相似文献

相关主题

期刊订阅